Form 10-Q CRISPR Therapeutics AG For: Jun 30

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. FIX

Go back to Form 10-Q CRISPR Therapeutics AG For: Jun 30

CRISPR Therapeutics (CRSP) PT Lowered to $60 at RBC Capital

August 6, 2024 6:43 AM EDT

RBC Capital analyst Luca Issi lowered the price target on CRISPR Therapeutics (NASDAQ: CRSP) to $60.00 (from $66.00) while maintaining a Sector Perform rating.

The analyst comments "Casgevys launch is under way with >35 ATCs activated (vs >25 last Q) and cells collected from 20... More